![]() |
|
|
National Institute of Nutrition, Indian Council of Medical Research, Hyderabad-500 007 A.P. India
2To whom correspondence should be addressed. E-mail: ghafoorunissanin@rediffmail.com; ghafoorunissanin{at}yahoo.com.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: insulin resistance dietary sucrose adipose tissue (n-3) long-chain polyunsaturated fatty acids rats
Insulin resistance is a major metabolic abnormality associated with several diet-related chronic diseases such as type 2 diabetes, obesity, hypertension, and coronary heart disease (1). Studies have demonstrated that the amount and the type of specific dietary fatty acids are important environmental determinants of insulin resistance (2). High intakes of SFAs lead to insulin resistance, whereas (n-3) PUFAs prevent the development of insulin resistance. Several lines of evidence documented that the (n-3) long-chain PUFAs (LCPUFAs),3 eicosapentaenoic acid [20:5(n-3)] and docosahexaenoic acid [22:6(n-3)], present in fish oil have potential antiatherothrombogenic effects (3). More recent studies in rats showed that fish oil prevented insulin resistance induced by diets containing high fat (4,5) or high sucrose (69). Storlien et al. (5) demonstrated that substitution of SFA with fish oil protected against insulin resistance. Further, in sucrose-induced insulin-resistant rats, we reported that substitution of dietary
-linolenic acid [18:3(n-3)] for linoleic acid [18:2(n-6)] improved peripheral insulin sensitivity (10).
In type 2 diabetics, fish oil supplementation was shown both to improve (11) and to worsen (12) glycemic control. The conflicting results could be due to differences in the dose of (n-3) LCPUFAs, the background diets, or differences in the intake of other fatty acids. To our knowledge, there is no information about the level of (n-3) LCPUFAs [particularly in relation to (n-6) PUFAs] needed to prevent insulin resistance. In the present study, mixtures of groundnut oil, palmolein, and fish oil were used to create a series of diets with differing levels of (n-3) LCPUFAs and ratios of (n-6) to (n-3) fatty acids. The effects of feeding these diets to sucrose-fed rats on plasma indices of insulin sensitivity including glucose and insulin concentrations and the insulin response to an oral glucose load were investigated. To investigate insulin sensitivity in target tissues of insulin action, adipocyte lipolysis and adipocyte glucose transport and phospholipid fatty acid composition of the diaphragm were studied.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Rats and diets.
All procedures involved in animal experiments were approved by the institutional animal ethical committee, National Institute of Nutrition, Hyderabad, India. Male Wistar rats (n = 80, National Institute of Nutrition), 3 wk old, were housed individually in polypropylene cages at 21 ± 1°C with a 12-h light:dark cycle. Rats were initially fed a standard rat diet (National Centre of Laboratory Animal Sciences, Hyderabad, India). After a 1-wk acclimation period, they were assigned randomly to 5 groups and fed experimental diets (Table 1) for 12 wk. Insulin resistance was induced by replacing starch (ST) with sucrose (SU). The dietary fats were formulated with groundnut oil, palmolein, and fish oil (Max EPA, Merck) to provide different ratios of (n-6) and (n-3) fatty acids. The fatty acid compositions of dietary fats were determined by GC as described earlier (13). The fatty acid composition of the diet (Table 1) was designed to maintain constant proportions of SFAs, monounsaturated fatty acids (MUFAs), and PUFAs [18:2(n-6) + (n-3) LCPUFAs] and differ only in the ratios of (n-6):(n-3) fatty acids. In the starch group (ST-210), the (n-6):(n-3) ratio was 210. The (n-6):(n-3) ratios in sucrose-fed rats were 210 (SU-210), 50 (SU-50), 10 (SU-10), and 5 (SU-5). The concentration of (n-3) LCPUFAs (g/kg diet) in the various groups were: 0.14 (ST-210, SU-210), 0.55 (SU-50), 2.6 (SU-10), and 4.6 (SU-5). Diets were prepared once weekly by adding the oils to the base mixture containing other nutrients and stored at 4°C before use. The oils and base mixtures were stored at 4°C until preparation of the diet. Fish oil was kept under an atmosphere of nitrogen and stored at 20°C. All of the diets were supplemented with
-tocopherol (0.015 g/kg diet) to prevent oxidation. Rats were given fresh diet every day and had free access to food and water. The food intake of individual rats was recorded daily and the body weight was recorded once each week.
|
At the end of the experimental period (12 wk), rats were deprived of food for 18 h, blood was collected in EDTA tubes, and plasma was separated (1500 x g for 20 min) and stored at 70°C until analysis. The rats were killed by CO2 asphyxiation. Liver, diaphragm, and epididymal and retroperitoneal fat pads were removed. A portion of the epididymal adipose tissue was put immediately into Bouins fixative and the cell size was measured using the procedure of Ashwell and Priest (15).
Adipocyte isolation. Adipocytes were isolated from the epididymal fat pad by collagenase digestion according to Rodbell (16). Briefly, minced epididymal fat pads were incubated with collagenase (1 mg/g tissue, type II, GIBCO, Invitrogen) at 37°C for 1 h in Krebs Ringer HEPES buffer (KRH, pH 7.4, 130 mmol/L NaCl, 1.4 mmol/L MgSO4, 5.2 mmol/L KCl, 1.4 mmol/L CaCl2, 1 mmol/L KH2PO4, 10 mmol/L HEPES containing 10 g/L bovine serum albumin and 2 mmol/L pyruvate). Adipocytes were washed 3 times with collagenase-free buffer and suspended in KRH buffer.
Adipocyte lipolysis and antilipolysis.
Lipolysis was assayed by measuring glycerol release into the incubation medium (17). Adipocytes (
2 x 108 cells/L) were incubated at 37°C in polyethylene tubes for 2 h in KRH buffer (pH 7.4) in a final volume of 0.5 mL. The antilipolytic effect of insulin was assessed by incubating adipocytes with 1 µmol/L norepinephrine (maximum stimulating concentration) and various concentrations of insulin (18). After 2 h of incubation, the tubes were placed in an ice bath and cells were separated from the medium by a brief centrifugation (500 x g for 1 min). The infranatant below the cell layer was removed and the glycerol content was estimated.
Adipocyte glucose transport.
Basal and insulin-stimulated glucose transport were measured as described (19). Adipocytes (
2 x 108 cells/L) were preincubated with and without various concentrations of porcine insulin at 37°C for 45 min. The cells were incubated with 2-[1,2-3H] deoxyglucose at a concentration of 0.1 mmol/L in KRH buffer (pH 7.4). The assay was terminated at the end of 3 min by transferring the assay mixture to a microcentrifuge tube containing silicone oil. The tubes were centrifuged at 3000 x g for 3 min. The top layer containing adipocytes was transferred to a liquid scintillation vial and radioactivity associated with adipocytes was measured in a liquid scintillation counter. All data were corrected for nonspecific transport by measuring glucose transport in the presence of 0.3 mmol/L phloretin.
Diaphragm lipid analysis. Diaphragm total lipids were extracted using the method of Folch (20). Neutral lipids were separated from phospholipids by TLC on silica gel G with hexane:diethyl ether:acetic acid (80:20:1 by vol) and the fatty acid methyl esters were analyzed by GC using a SP-2330 capillary column (30 m x 0.25 mm i.d., Supelco) as described earlier (13). Diaphragm triglycerides were quantitated using an enzymatic assay kit (glycerol phosphate oxidase/peroxidase kit) from Biosystems. Protein was estimated by Lowrys method (21).
Plasma analysis. Plasma glucose (glucose oxidase/peroxidase kit), triglycerides (glycerol phosphate oxidase/peroxidase kit), and cholesterol (cholesterol oxidase/peroxidase kit) were estimated using enzymatic methods (Biosystems) and insulin by RIA using a kit (RIAK-1) from BRIT.
Statistical analysis. Statistical analysis was done using the SPSS statistical program. All of the values are presented as means ± SEM. Data were evaluated by one-way ANOVA followed by least square difference (LSD) post hoc tests. Differences of P < 0.05 were considered significant.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
-linolenic acid [18:3(n-3)] at 11 g/kg diet [(n-6):(n-3) ratio = 2] improved insulin sensitivity in sucrose-fed rats (10). The present study demonstrated that substitution of (n-3) LCPUFAs for linoleic acid without changing the total PUFA, SFA, and MUFA prevented the sucrose-induced insulin resistance. The minimum amount of (n-3) LCPUFAs required for prevention of hyperinsulinemic response to a glucose challenge was 2.6 g/kg diet [(n-6):(n-3) ratio = 10]. The observed decrease in compensatory insulin response in (n-3) LCPUFA-fed rats suggests an increase in insulin sensitivity. Fish oils were shown to decrease visceral adiposity (25). In the present study, sucrose feeding was associated with an increase in adipose tissue weight and body weight, which could be due to increased energy intake. The lack of effect of (n-3) LCPUFAs in reducing the visceral adiposity in sucrose-fed rats suggests that >4.6 g/kg diet of (n-3) LCPUFAs may be needed to reduce visceral adiposity. Several animal and human studies showed that (n-3) LCPUFAs decrease plasma triglyceride levels dose dependently (26,27). In the present study 0.5 g/kg diet of (n-3) LCPUFAs [(n-6):(n-3) ratio of 50] normalized the sucrose-induced increase in plasma triglycerides. It therefore appears that the dose of (n-3) LCPUFAs required for the hypotriglyceridemic effect may be lower than the level needed for the prevention of hyperinsulinemia.
The mechanism by which dietary (n-3) LCPUFAs prevent insulin resistance remains unclear. Adipose tissue releases FFA and adipocytokines into the circulation, and its metabolic activity is the main contributor to the development of insulin resistance (28). The present study suggests that a decrease in adipocyte lipolysis by (n-3) LCPUFAs could play an important role in increasing insulin sensitivity by reducing the fatty acid availability and increasing glucose utilization as reported by Randle et al. (29). The fatty acid composition of membrane phospholipids of insulin target tissues is an important factor influencing insulin sensitivity through their effect on insulin receptor and the glucose transporter (GLUT4). Studies showed that the (n-3) LCPUFA content in adipose tissue and skeletal muscle phospholipids contributes to efficient insulin action (5,6). We reported earlier (10) that the increase in (n-3) LCPUFAs in adipocyte plasma membrane and diaphragm in rats fed high levels of 18:3 (n-3) in sucrose-based diets was associated with an improvement in insulin sensitivity. Girion et al. (30) demonstrated that dietary fish oil supplementation increased the expression of GLUT4 mRNA in skeletal muscle of diabetic rats. The observed increase of (n-3) LCPUFAs in diaphragm phospholipids and therefore possibly in all skeletal muscle and adipocyte plasma membrane could have contributed to the reversal of insulin resistance in sucrose-fed rats. Another mechanism by which (n-3) LCPUFAs may improve insulin action could be through correction of hyperinsulinemia. Del Parto et al. (31) showed that hyperinsulinemia caused by either exogenous insulin infusion or endogenous insulin secretion induced insulin resistance. In this context, a recent study indicated that sucrose feeding increased fat storage and decreased pyruvate dehydrogenase complex activity in the ß cell of the pancreas, resulting in abnormal secretion of insulin and peripheral insulin resistance (32). Supplementation of fish oil reversed these alterations. Thus, correction of hyperinsulinemia could be one mechanism by which (n-3) LCPUFAs prevent sucrose-induced insulin resistance. Alternatively, (n-3) LCPUFAs could prevent insulin resistance by a direct membrane independent effect on gene expression. The (n-3) LCPUFAs regulate the transcription of several genes involved in glucose and lipid metabolism (33,34). It is also possible that (n-3) LCPUFAs may improve insulin sensitivity through upregulation of the intracellular insulin signaling pathway (35). Recent studies indicated that adipose tissues produce and release a number of proteins collectively known as adipocytokines, which may play a major role in the prevention of insulin resistance. Leptin and adiponectin were shown to prevent insulin resistance, whereas resistin and tumor necrosis factor
induced insulin resistance (36). Indeed, cell culture (37) and animal studies (38) reported that (n-3) LCPUFAs upregulate leptin mRNA expression and secretion. Further, (n-3) LCPUFAs were shown to ameliorate conjugated linoleic acidinduced insulin resistance by upregulating the expression of leptin and adiponectin (39). These studies suggest that the beneficial effects of (n-3) LCPUFAs in preventing insulin resistance may be exerted indirectly through adipocytokines.
In conclusion, the results of the present study demonstrate that in diets providing 28 g of 18:2 (n-6)/kg diet, substitution of
10% of (n-3) LCPUFAs [(n-6):(n-3) ratio = 10] prevented sucrose-induced insulin resistance in rats, and these effects may be mediated through incorporation of (n-3) LCPUFAs in membrane lipids. Thus, inclusion of fish in the diets or use of fish oil supplements may be beneficial for alleviation and prevention of insulin resistance and for reducing the risk of associated chronic diseases.
| FOOTNOTES |
|---|
3 Abbreviations used: GLUT, glucose transporter; KRH, Krebs Ringer HEPES buffer; LCPUFA, long-chain PUFA; MUFA, monounsaturated fatty acid; ST, starch; SU, sucrose; ST-210, SU-210, SU-50, SU-10, SU-5, starch and sucrose diets with (n-6):(n-3) fatty acid ratios of 210, 50, 10, and 5. ![]()
Manuscript received 13 February 2005. Initial review completed 18 April 2005. Revision accepted 2 August 2005.
| LITERATURE CITED |
|---|
|
|
|---|
1. Hauner H. Insulin resistance and the metabolic syndromea challenge of the new millennium. Eur. J. Clin. Nutr. 2002;56:S25-S29.
2. Lichtenstein A. H., Schwab U. S. Relationship of dietary fat to glucose metabolism. Atherosclerosis. 2000;150:227-243.[Medline]
3. Mori T. A., Beilin L. J. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr. Opin. Lipidol. 2001;12:11-17.[Medline]
4. Storlien L. H., Kraegen E. W., Chisholm D. J., Ford G. L., Bruce D. G., Pascoe W. S. Fish oil prevents insulin resistance induced by high fat feeding in rats. Science (Washington, DC). 1987;237:885-888.
5. Storlien L. H., Jenkins A. B., Chisholm D. J., Pascoe W. S., Khouri S., Kraegen E. W. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3-fatty acids in muscle phospholipid. Diabetes. 1991;40:280-289.[Abstract]
6. Luo J., Rizkalla S. W., Boillot J., Alamowitch C., Chaib H., Bruzzo F., Desplanque N., Dalix A. M., Durand G., Slama G. Dietary (n-3) polyunsaturated fatty acids improve adipocyte insulin action and glucose metabolism in insulin-resistant rats: relation to membrane fatty acids. J. Nutr. 1996;126:1951-1958.
7. DAlessandro M. E., Chicco A., Karabatas L., Lombardo Y. B. Role of skeletal muscle on impaired insulin sensitivity in rats fed a sucrose-rich diet: effect of moderate levels of dietary fish oil. J. Nutr. Biochem. 2000;11:273-280.[Medline]
8. Peyron-Caso E., Fluteau-Nadler S., Kabir M., Guerre-Millo M., Quignard-Boulange A., Slama G., Rizkalla S. W. Regulation of glucose transport and transporter 4 (GLUT-4) in muscle and adipocytes of sucrose fed rats: effects of n-3 poly and monounsaturated fatty acids. Horm. Metab. Res. 2002;34:360-366.[Medline]
9. Podolin D. A., Gayles E. C., Wei Y., Thresher J. S., Pagliassotti M. J. Menhaden oil prevents but does not reverse sucrose-induced insulin resistance in rats. Am. J. Physiol. 1998;274:R840-R848.
10. Ghafoorunissa , Ibrahim A., Natarajan S. Substituting dietary linoleic acids with
-linolenic acid improves insulin sensitivity in sucrose fed rats. Biochem. Biophys. Acta. 2005;1733:67-75.[Medline]
11. Malasanos T. H., Stacpoole P. W. Biological effects of omega-3-fatty acids in diabetes mellitus. Diabetes Care. 1991;14:1160-1179.[Abstract]
12. Glauber H., Wallace P., Griver K., Brechtel G. Adverse metabolic effect of omega-3 fatty acids in non-insulin dependent diabetes mellitus. Ann. Intern. Med. 1988;108:663-668.
13. Ghafoorunissa , Reddy V., Sesikeran B. Palmolein and groundnut oil have comparable effects on blood lipids and platelet aggregation in healthy Indian subjects. Lipids. 1995;30:1163-1169.[Medline]
14. Reeves P. G., Nielsen F. H., Fahey G. C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993;123:1939-1951.
15. Ashwell M., Priest P., Bondoux M., Sowter C., McPherson C. K. Human fat cell sizinga quick, simple method. J. Lipid Res. 1976;17:190-192.[Abstract]
16. Rodbell M. Metabolism of isolated fat cells: effects on hormones on glucose metabolism and lipolysis. J. Biol. Chem. 1964;239:375-380.
17. Honnor R. C., Dhillon G. S., Londos C. cAMP-dependent protein kinase and lipolysis in rat adipocytes. J. Biol. Chem. 1985;260:15122-15129.
18. Morimoto C., Tsujita T., Okuda H. Antilipolytic actions of insulin on basal and hormone-induced lipolysis in rat adipocytes. J. Lipid Res. 1998;39:957-962.
19. Wilkes J. J., Bonen A., Bell R. C. A modified high fat diet induces insulin resistance in rat skeletal muscle but not adipocytes. Am. J. Physiol. 1998;275:E679-E686.
20. Folch J., Lees M., Sloane-Stanley G. H. A simple method of the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957;226:497-509.
21. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265-275.
22. DAlessandro M. E., Lombardo Y. B., Chicco A. Effect of dietary fish oil on insulin sensitivity and metabolic fate of glucose in the skeletal muscle of normal rats. Ann. Nutr. Metab. 2002;46:114-120.[Medline]
23. Chicco A., DAlessandro M. E., Karabatas L., Pastorale C., Basabe J. C., Lombardo Y. B. Muscle lipid metabolism and insulin secretion are altered in insulin-resistant rats fed a high sucrose diet. J. Nutr. 2003;133:127-133.
24. Pagliassotti M. J., Kang J., Thresher J. S., Sung C. K., Bizeau M. E. Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance. Am. J. Physiol. 2002;282:E170-E176.
25. Parrish C. C., Pathy D. A., Angel A. Dietary fish oils limit adipose tissue hypertrophy in rats. Metabolism. 1990;39:217-219.[Medline]
26. Schmidt E. B., Varming K., Ernst E., Madsen P., Dyerberg J. Dose-response studies on the effect of (n-3) polyunsaturated fatty acids on lipids and haemostasis. Thromb. Haemost. 1990;63:1-5.[Medline]
27. Roche H. M., Gibney M. J. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and post prandial triacylglycerol metabolism. Am. J. Clin. Nutr. 2000;71:232S-237S.
28. Lewis G. F., Carpentier -A., Adeli K., Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 2002;23:201-229.
29. Randle P. J., Garland P. B., Hales C. N., Newsholme E. A. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.[Medline]
30. Girion M. D., Salto R., Hortelano P., Periago J. L., Vargas A. M., Suarez M. D. Increased diaphragm expression of GLUT 4 in control and streptozotocin-diabetic rats by fish oil supplemented diets. Lipids. 1999;34:801-807.[Medline]
31. Del Prato S., Leonetti F., Simonson D. C., Sheehan P., Matsuda M., DeFronzo R. A. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia. 1994;37:1025-1035.[Medline]
32. Pighin D., Karabatas L, Rossi A., Chicco A., Basabe J. C., Lombardo Y. B. Fish oil affects pancreatic fat storage, pyruvate dehydrogenase complex activity and insulin secretion in rats fed a sucrose-rich diet. J. Nutr. 2003;133:4095-4101.
33. Clarke S. D. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br. J. Nutr. 2000;83:S59-S66.
34. Clarke S. D. Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J. Nutr. 2001;131:1129-1132.
35. Murata M., Kaji H., Iida K., Okimura Y., Chihara K. Dual action of eicosapentaenoic acid in hepatoma cells. Up-regulation of metabolic action of insulin and inhibition of cell proliferation. J. Biol. Chem. 2001;276:31422-31428.
36. Pittas A. G., Joseph N. A., Greenberg A. S. Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab. 2004;89:447-452.
37. Murata M., Kaji H., Takahashi Y., Iida K., Mizuno I., Okimura Y., Abe H., Chihara K. Stimulation by eicosapentaenoic acids of leptin mRNA expression and its secretion in mouse 3T3L1 adipocytes in vitro. Biochem. Biophys. Res. Commun. 2000;270:343-348.[Medline]
38. Peyron-Caso P., Taverna M., Guerre-Millo M., Veronese A., Pacher N., Slama G., Rizkalla S. W. Dietary (n-3) polyunsaturated fatty acids up-regulate plasma leptin in insulin resistant rats. J. Nutr. 2002;132:2235-2240.
39. Ide T. Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes. 2005;54:412-423.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||